Correlates of Lymphedema in Women with Breast Cancer: a Case Control Study in Shiraz, Southern Iran.
Identifieur interne : 001235 ( Main/Exploration ); précédent : 001234; suivant : 001236Correlates of Lymphedema in Women with Breast Cancer: a Case Control Study in Shiraz, Southern Iran.
Auteurs : Behnam Honarvar [Oman] ; Negin Sayar ; Sedigheh Tahmasebi ; Zeinab Zakeri ; Asra Talei ; Sara Rostami ; Sahar Khademi ; Amene Sabzi Sarvestani ; Eghbal SekhavatiSource :
- Asian Pacific journal of cancer prevention : APJCP [ 2476-762X ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Invasion tumorale, Iran, Lymphadénectomie, Lymphoedème (diagnostic), Lymphoedème (étiologie), Mastectomie (effets indésirables), Membre supérieur (anatomopathologie), Métastase lymphatique, Pronostic, Qualité de vie, Stade de la tumeur, Survivants, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Études cas-témoins, Études de suivi.
- MESH :
- anatomopathologie : Membre supérieur, Tumeurs du sein.
- diagnostic : Lymphoedème.
- effets indésirables : Mastectomie.
- étiologie : Lymphoedème.
- Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Invasion tumorale, Iran, Lymphadénectomie, Métastase lymphatique, Pronostic, Qualité de vie, Stade de la tumeur, Survivants, Tumeurs du sein, Études cas-témoins, Études de suivi.
English descriptors
- KwdEn :
- Breast Neoplasms (pathology), Breast Neoplasms (surgery), Case-Control Studies, Female, Follow-Up Studies, Humans, Iran, Lymph Node Excision, Lymphatic Metastasis, Lymphedema (diagnosis), Lymphedema (etiology), Mastectomy (adverse effects), Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Prognosis, Quality of Life, Risk Factors, Survivors, Upper Extremity (pathology).
- MESH :
- adverse effects : Mastectomy.
- diagnosis : Lymphedema.
- etiology : Lymphedema.
- pathology : Breast Neoplasms, Upper Extremity.
- surgery : Breast Neoplasms.
- Case-Control Studies, Female, Follow-Up Studies, Humans, Iran, Lymph Node Excision, Lymphatic Metastasis, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Prognosis, Quality of Life, Risk Factors, Survivors.
Abstract
Globally, the burden of breast cancer (BC) continues to increase. BC related lymphedema (BCRL) is currently non curable and as a life time risk it affects at least 25% of BC patients. Knowing more about BCRL and appropriate control of its modifiable risk factors can improve quality of life (QOL) of the affected patients. In this case control study to detect factors, 400 women with BCRL (as the case group) and 283 patients with BC without lymphedema (as the control group) that were referred to Shiraz University of Medical Sciences affiliated BC clinic center were assessed. The data were analyzed in SPSS. The mean age of the case group was 52.3±11.0 years and of the control group was 50.1±10.9 years. In patients with BCRL, 203(50.7%) had left (Lt) side BC and in non- lymphedema group 151 (53.3%) had Lt side BC. Out of all BCRL patients, 204 (51%) had lymphedema in all parts of their affected upper extremities, 100 (25%) had swelling in the arm and forearm and 23 (5.7%) had edema in both the upper extremity and trunk. Edema, heaviness, concern about changing body image, pain and paresthesia were the most common signs/symptoms among patients with BCRL. In BCRL patients, the difference of circumference between the affected upper limb and non-affected limb was 4.4±2.5 cm and the difference in volume displacement was 528.7±374.4 milliliters. Multiple variable analysis showed that moderate to severe activity (OR; odds ratio =14, 95% CI: 2.6-73.3 ), invasiveness of BC (OR =13.7, 95% CI: 7.3-25.6), modified radical mastectomy (OR=4.3, 95% CI: 2.3-7.9), BMI =>25 (OR=4.2, 95% CI: 2-8.7), radiotherapy (OR=3.9, 95% CI: 1.8-8.2 ), past history of limb damage (OR=1.7, 95% CI: 0.9-3.1) and the number of excised lymph nodes (OR=1.06, 95% CI: 1.02-1.09) were the significant predictors of lymphedema in women with BC. Modifiable risk factors of BCRL such as non-guided moderate to severe physical activity, high BMI and trauma to the limb should be controlled as early as possible in BC patients to prevent development of BCRL and improve QOL of these patients.
PubMed: 27165213
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000833
- to stream PubMed, to step Curation: 000833
- to stream PubMed, to step Checkpoint: 000833
- to stream Ncbi, to step Merge: 008273
- to stream Ncbi, to step Curation: 008273
- to stream Ncbi, to step Checkpoint: 008273
- to stream Main, to step Merge: 001237
- to stream Main, to step Curation: 001235
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Correlates of Lymphedema in Women with Breast Cancer: a Case Control Study in Shiraz, Southern Iran.</title>
<author><name sortKey="Honarvar, Behnam" sort="Honarvar, Behnam" uniqKey="Honarvar B" first="Behnam" last="Honarvar">Behnam Honarvar</name>
<affiliation wicri:level="1"><nlm:affiliation>Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran E-mail: sayar.negin@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz</wicri:regionArea>
<wicri:noRegion>Shiraz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sayar, Negin" sort="Sayar, Negin" uniqKey="Sayar N" first="Negin" last="Sayar">Negin Sayar</name>
</author>
<author><name sortKey="Tahmasebi, Sedigheh" sort="Tahmasebi, Sedigheh" uniqKey="Tahmasebi S" first="Sedigheh" last="Tahmasebi">Sedigheh Tahmasebi</name>
</author>
<author><name sortKey="Zakeri, Zeinab" sort="Zakeri, Zeinab" uniqKey="Zakeri Z" first="Zeinab" last="Zakeri">Zeinab Zakeri</name>
</author>
<author><name sortKey="Talei, Asra" sort="Talei, Asra" uniqKey="Talei A" first="Asra" last="Talei">Asra Talei</name>
</author>
<author><name sortKey="Rostami, Sara" sort="Rostami, Sara" uniqKey="Rostami S" first="Sara" last="Rostami">Sara Rostami</name>
</author>
<author><name sortKey="Khademi, Sahar" sort="Khademi, Sahar" uniqKey="Khademi S" first="Sahar" last="Khademi">Sahar Khademi</name>
</author>
<author><name sortKey="Sabzi Sarvestani, Amene" sort="Sabzi Sarvestani, Amene" uniqKey="Sabzi Sarvestani A" first="Amene" last="Sabzi Sarvestani">Amene Sabzi Sarvestani</name>
</author>
<author><name sortKey="Sekhavati, Eghbal" sort="Sekhavati, Eghbal" uniqKey="Sekhavati E" first="Eghbal" last="Sekhavati">Eghbal Sekhavati</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27165213</idno>
<idno type="pmid">27165213</idno>
<idno type="wicri:Area/PubMed/Corpus">000833</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000833</idno>
<idno type="wicri:Area/PubMed/Curation">000833</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000833</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000833</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000833</idno>
<idno type="wicri:Area/Ncbi/Merge">008273</idno>
<idno type="wicri:Area/Ncbi/Curation">008273</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">008273</idno>
<idno type="wicri:Area/Main/Merge">001237</idno>
<idno type="wicri:Area/Main/Curation">001235</idno>
<idno type="wicri:Area/Main/Exploration">001235</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Correlates of Lymphedema in Women with Breast Cancer: a Case Control Study in Shiraz, Southern Iran.</title>
<author><name sortKey="Honarvar, Behnam" sort="Honarvar, Behnam" uniqKey="Honarvar B" first="Behnam" last="Honarvar">Behnam Honarvar</name>
<affiliation wicri:level="1"><nlm:affiliation>Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran E-mail: sayar.negin@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz</wicri:regionArea>
<wicri:noRegion>Shiraz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sayar, Negin" sort="Sayar, Negin" uniqKey="Sayar N" first="Negin" last="Sayar">Negin Sayar</name>
</author>
<author><name sortKey="Tahmasebi, Sedigheh" sort="Tahmasebi, Sedigheh" uniqKey="Tahmasebi S" first="Sedigheh" last="Tahmasebi">Sedigheh Tahmasebi</name>
</author>
<author><name sortKey="Zakeri, Zeinab" sort="Zakeri, Zeinab" uniqKey="Zakeri Z" first="Zeinab" last="Zakeri">Zeinab Zakeri</name>
</author>
<author><name sortKey="Talei, Asra" sort="Talei, Asra" uniqKey="Talei A" first="Asra" last="Talei">Asra Talei</name>
</author>
<author><name sortKey="Rostami, Sara" sort="Rostami, Sara" uniqKey="Rostami S" first="Sara" last="Rostami">Sara Rostami</name>
</author>
<author><name sortKey="Khademi, Sahar" sort="Khademi, Sahar" uniqKey="Khademi S" first="Sahar" last="Khademi">Sahar Khademi</name>
</author>
<author><name sortKey="Sabzi Sarvestani, Amene" sort="Sabzi Sarvestani, Amene" uniqKey="Sabzi Sarvestani A" first="Amene" last="Sabzi Sarvestani">Amene Sabzi Sarvestani</name>
</author>
<author><name sortKey="Sekhavati, Eghbal" sort="Sekhavati, Eghbal" uniqKey="Sekhavati E" first="Eghbal" last="Sekhavati">Eghbal Sekhavati</name>
</author>
</analytic>
<series><title level="j">Asian Pacific journal of cancer prevention : APJCP</title>
<idno type="eISSN">2476-762X</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Case-Control Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Iran</term>
<term>Lymph Node Excision</term>
<term>Lymphatic Metastasis</term>
<term>Lymphedema (diagnosis)</term>
<term>Lymphedema (etiology)</term>
<term>Mastectomy (adverse effects)</term>
<term>Middle Aged</term>
<term>Neoplasm Invasiveness</term>
<term>Neoplasm Staging</term>
<term>Prognosis</term>
<term>Quality of Life</term>
<term>Risk Factors</term>
<term>Survivors</term>
<term>Upper Extremity (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Invasion tumorale</term>
<term>Iran</term>
<term>Lymphadénectomie</term>
<term>Lymphoedème (diagnostic)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mastectomie (effets indésirables)</term>
<term>Membre supérieur (anatomopathologie)</term>
<term>Métastase lymphatique</term>
<term>Pronostic</term>
<term>Qualité de vie</term>
<term>Stade de la tumeur</term>
<term>Survivants</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Études cas-témoins</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Mastectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Membre supérieur</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Mastectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term>
<term>Upper Extremity</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Case-Control Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Iran</term>
<term>Lymph Node Excision</term>
<term>Lymphatic Metastasis</term>
<term>Middle Aged</term>
<term>Neoplasm Invasiveness</term>
<term>Neoplasm Staging</term>
<term>Prognosis</term>
<term>Quality of Life</term>
<term>Risk Factors</term>
<term>Survivors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Invasion tumorale</term>
<term>Iran</term>
<term>Lymphadénectomie</term>
<term>Métastase lymphatique</term>
<term>Pronostic</term>
<term>Qualité de vie</term>
<term>Stade de la tumeur</term>
<term>Survivants</term>
<term>Tumeurs du sein</term>
<term>Études cas-témoins</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Globally, the burden of breast cancer (BC) continues to increase. BC related lymphedema (BCRL) is currently non curable and as a life time risk it affects at least 25% of BC patients. Knowing more about BCRL and appropriate control of its modifiable risk factors can improve quality of life (QOL) of the affected patients. In this case control study to detect factors, 400 women with BCRL (as the case group) and 283 patients with BC without lymphedema (as the control group) that were referred to Shiraz University of Medical Sciences affiliated BC clinic center were assessed. The data were analyzed in SPSS. The mean age of the case group was 52.3±11.0 years and of the control group was 50.1±10.9 years. In patients with BCRL, 203(50.7%) had left (Lt) side BC and in non- lymphedema group 151 (53.3%) had Lt side BC. Out of all BCRL patients, 204 (51%) had lymphedema in all parts of their affected upper extremities, 100 (25%) had swelling in the arm and forearm and 23 (5.7%) had edema in both the upper extremity and trunk. Edema, heaviness, concern about changing body image, pain and paresthesia were the most common signs/symptoms among patients with BCRL. In BCRL patients, the difference of circumference between the affected upper limb and non-affected limb was 4.4±2.5 cm and the difference in volume displacement was 528.7±374.4 milliliters. Multiple variable analysis showed that moderate to severe activity (OR; odds ratio =14, 95% CI: 2.6-73.3 ), invasiveness of BC (OR =13.7, 95% CI: 7.3-25.6), modified radical mastectomy (OR=4.3, 95% CI: 2.3-7.9), BMI =>25 (OR=4.2, 95% CI: 2-8.7), radiotherapy (OR=3.9, 95% CI: 1.8-8.2 ), past history of limb damage (OR=1.7, 95% CI: 0.9-3.1) and the number of excised lymph nodes (OR=1.06, 95% CI: 1.02-1.09) were the significant predictors of lymphedema in women with BC. Modifiable risk factors of BCRL such as non-guided moderate to severe physical activity, high BMI and trauma to the limb should be controlled as early as possible in BC patients to prevent development of BCRL and improve QOL of these patients.</div>
</front>
</TEI>
<affiliations><list><country><li>Oman</li>
</country>
</list>
<tree><noCountry><name sortKey="Khademi, Sahar" sort="Khademi, Sahar" uniqKey="Khademi S" first="Sahar" last="Khademi">Sahar Khademi</name>
<name sortKey="Rostami, Sara" sort="Rostami, Sara" uniqKey="Rostami S" first="Sara" last="Rostami">Sara Rostami</name>
<name sortKey="Sabzi Sarvestani, Amene" sort="Sabzi Sarvestani, Amene" uniqKey="Sabzi Sarvestani A" first="Amene" last="Sabzi Sarvestani">Amene Sabzi Sarvestani</name>
<name sortKey="Sayar, Negin" sort="Sayar, Negin" uniqKey="Sayar N" first="Negin" last="Sayar">Negin Sayar</name>
<name sortKey="Sekhavati, Eghbal" sort="Sekhavati, Eghbal" uniqKey="Sekhavati E" first="Eghbal" last="Sekhavati">Eghbal Sekhavati</name>
<name sortKey="Tahmasebi, Sedigheh" sort="Tahmasebi, Sedigheh" uniqKey="Tahmasebi S" first="Sedigheh" last="Tahmasebi">Sedigheh Tahmasebi</name>
<name sortKey="Talei, Asra" sort="Talei, Asra" uniqKey="Talei A" first="Asra" last="Talei">Asra Talei</name>
<name sortKey="Zakeri, Zeinab" sort="Zakeri, Zeinab" uniqKey="Zakeri Z" first="Zeinab" last="Zakeri">Zeinab Zakeri</name>
</noCountry>
<country name="Oman"><noRegion><name sortKey="Honarvar, Behnam" sort="Honarvar, Behnam" uniqKey="Honarvar B" first="Behnam" last="Honarvar">Behnam Honarvar</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001235 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001235 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:27165213 |texte= Correlates of Lymphedema in Women with Breast Cancer: a Case Control Study in Shiraz, Southern Iran. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27165213" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |